Investigate the relationship between Methyl 4-(butyrylamino)-3-methyl-5-nitrobenzoate (CAS 152628-01-8) and Telmisartan impurity profiles. Learn how high-purity intermediates are key to minimizing unwanted byproducts in pharmaceutical synthesis.
